Skip to main content

Table 1 N. gonorrhoeae with decreased susceptibility* to cefixime, ceftriaxone, and resistance to ciprofloxacin and penicillin in Switzerland, 1990–2012

From: Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012

 

Cefixime

Ceftriaxone

Ciprofloxacin

Penicillin

Year

Tested, n#

DS, n (%)

(95% CI)

Tested, n#

DS, n (%)

(95% CI)

Tested, n#

R, n (%)

(95% CI)

Tested, n#

R, n (%)

(95% CI)

1990

16

0 (0)

(0–21)

16

0 (0)

(0–21)

42

1 (2.4)

(0–12)

42

9 (21.4)

(10–37)

2000-2002

7

0 (0)

(0–40)

7

0 (0)

(0–40)

33

10 (30.3)

(15–48)

33

4 (12.1)

(3–28)

2003/2004

10

0 (0)

(0–30)

10

0 (0)

(0–30)

33

16 (48.5)

(31–66)

33

13 (39.4)

(23–58)

2005/2006

17

0 (0)

(0–19)

32

0 (0)

(0–11)

36

21 (58.3)

(41–74)

31

7 (22.6)

(10–41)

2007/2008

48

5 (10.4)

(3.4-22)

85

2 (2.4)

(0.3-8)

85

62 (72.9)

(62–82)

84

25 (29.8)

(20–41)

2009/2010

26

3 (11.5)

(2.4-30)

43

2 (4.7)

(0.5-16)

43

31 (72.1)

(56–84)

43

7 (16.3)

(7–30)

2011/2012

35

4 (11.4)

(3.2-26)

46

0 (0)

(0–8)

44

32 (72.7)

(57–85)

44

10 (22.7)

(11–38)

Total

159

  

239

  

317

  

311

  
  1. Abbreviations: CI, confidence interval of the proportion; DS, decreased susceptibility; R, resistant.
  2. *Decreased susceptibility to cefixime and ceftriaxone defined by minimal inhibitory concentration (MIC) >0.125 mg/L. Ciprofloxacin resistance defined by MIC >0.064 mg/L, and penicillin resistance defined by MIC >1.0/L or penicillinase-producing strains, according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST).
  3. #The 42 isolates from 1990 and the 66 isolates from 2000–2004 were stored at -70°C and subcultured in 2005 for testing for penicillin and ciprofloxacin; and in 2011 for cefixime and ceftriaxone. The 36 strains from 2005/2006, the 85 strains from 2007/2008, the 43 strains from 2009/2010, and the 44 strains from 2011/2012 were tested under routine conditions for penicillin, ciprofloxacin and ceftriaxone. In 2011 the viable strains were tested for cefixime. By the end of 2011, all strains were tested routinely for penicillin, ciprofloxacin, ceftriaxone and cefepime. This explains why the number of strains tested in each period differs for each antibiotic.